{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T14:19:27Z","timestamp":1793110767358,"version":"4.5.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,4,5]],"date-time":"2020-04-05T00:00:00Z","timestamp":1586044800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,4,5]],"date-time":"2020-04-05T00:00:00Z","timestamp":1586044800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science","award":["17K10866"],"award-info":[{"award-number":["17K10866"]}]},{"name":"Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science","award":["17K10865"],"award-info":[{"award-number":["17K10865"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["acta neuropathol commun"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Glioblastoma (GBM) is characterized by extensive tumor cell invasion, angiogenesis, and proliferation. We previously established subclones of GBM cells with distinct invasive phenotypes and identified annexin A2 (ANXA2) as an activator of angiogenesis and perivascular invasion. Here, we further explored the role of ANXA2 in regulating phenotypic transition in GBM. We identified oncostatin M receptor (OSMR) as a key ANXA2 target gene in GBM utilizing microarray analysis and hierarchical clustering analysis of the Ivy Glioblastoma Atlas Project and The Cancer Genome Atlas datasets. Overexpression of ANXA2 in GBM cells increased the expression of OSMR and phosphorylated signal transducer and activator of transcription 3 (STAT3) and enhanced cell invasion, angiogenesis, proliferation, and mesenchymal transition. Silencing of OSMR reversed the ANXA2-induced phenotype, and STAT3 knockdown reduced OSMR protein expression. Exposure of GBM cells to hypoxic conditions activated the ANXA2\u2013STAT3\u2013OSMR signaling axis. Mice bearing ANXA2-overexpressing GBM exhibited shorter survival times compared with control tumor-bearing mice, whereas OSMR knockdown increased the survival time and diminished ANXA2-mediated tumor invasion, angiogenesis, and growth. Further, we uncovered a significant relationship between ANXA2 and OSMR expression in clinical GBM specimens, and demonstrated their correlation with tumor histopathology and patient prognosis. Our results indicate that the ANXA2\u2013STAT3\u2013OSMR axis regulates malignant phenotypic changes and mesenchymal transition in GBM, suggesting that this axis is a promising therapeutic target to treat GBM aggressiveness.<\/jats:p>","DOI":"10.1186\/s40478-020-00916-7","type":"journal-article","created":{"date-parts":[[2020,4,5]],"date-time":"2020-04-05T21:02:41Z","timestamp":1586120561000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Annexin A2\u2013STAT3\u2013Oncostatin M receptor axis drives phenotypic and mesenchymal changes in glioblastoma"],"prefix":"10.1186","volume":"8","author":[{"given":"Yuji","family":"Matsumoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomotsugu","family":"Ichikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiko","family":"Kurozumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Otani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Fujimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kentaro","family":"Fujii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Tomita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiko","family":"Hattori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsuhito","family":"Uneda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobushige","family":"Tsuboi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keisuke","family":"Kaneda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keigo","family":"Makino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isao","family":"Date","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,4,5]]},"reference":[{"key":"916_CR1","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/nature08460","volume":"462","author":"DA Barbie","year":"2009","unstructured":"Barbie DA, Tamayo P, Boehm JS, Kim SY, Moody SE, Dunn IF, Schinzel AC, Sandy P, Meylan E, Scholl C et al (2009) Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1. Nature 462:108\u2013112. https:\/\/doi.org\/10.1038\/nature08460","journal-title":"Nature"},{"key":"916_CR2","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1007\/BF02633959","volume":"29a","author":"ME Berens","year":"1993","unstructured":"Berens ME, Bjotvedt G, Levesque DC, Rief MD, Shapiro JR, Coons SW (1993) Tumorigenic, invasive, karyotypic, and immunocytochemical characteristics of clonal cell lines derived from a spontaneous canine anaplastic astrocytoma. In Vitro Cell Dev Biol Anim 29a:310\u2013318","journal-title":"In Vitro Cell Dev Biol Anim"},{"key":"916_CR3","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.ccr.2013.08.001","volume":"24","author":"KPL Bhat","year":"2013","unstructured":"Bhat KPL, Balasubramaniyan V, Vaillant B, Ezhilarasan R, Hummelink K, Hollingsworth F, Wani K, Heathcock L, James JD, Goodman LD et al (2013) Mesenchymal differentiation mediated by NF-kappaB promotes radiation resistance in glioblastoma. Cancer Cell 24:331\u2013346. https:\/\/doi.org\/10.1016\/j.ccr.2013.08.001 {Bhat H, 2014 #271}","journal-title":"Cancer Cell"},{"key":"916_CR4","doi-asserted-by":"publisher","unstructured":"Brennan CW, Verhaak RG, McKenna A, Campos B, Noushmehr H, Salama SR, Zheng S, Chakravarty D, Sanborn JZ, Berman SHet al (2013) The somatic genomic landscape of glioblastoma. Cell 155: 462\u2013477 Doi https:\/\/doi.org\/10.1016\/j.cell.2013.09.034","DOI":"10.1016\/j.cell.2013.09.034"},{"key":"916_CR5","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1038\/nature08712","volume":"463","author":"MS Carro","year":"2010","unstructured":"Carro MS, Lim WK, Alvarez MJ, Bollo RJ, Zhao X, Snyder EY, Sulman EP, Anne SL, Doetsch F, Colman H et al (2010) The transcriptional network for mesenchymal transformation of brain tumours. Nature 463:318\u2013325. https:\/\/doi.org\/10.1038\/nature08712","journal-title":"Nature"},{"key":"916_CR6","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3892\/ijo.2017.4197","volume":"52","author":"MV Christensen","year":"2018","unstructured":"Christensen MV, Hogdall CK, Jochumsen KM, Hogdall EVS (2018) Annexin A2 and cancer: a systematic review. Int J Oncol 52:5\u201318. https:\/\/doi.org\/10.3892\/ijo.2017.4197","journal-title":"Int J Oncol"},{"key":"916_CR7","doi-asserted-by":"crossref","first-page":"3155","DOI":"10.1242\/jcs.114.17.3155","volume":"114","author":"DA Eberhard","year":"2001","unstructured":"Eberhard DA, Karns LR, VandenBerg SR, Creutz CE (2001) Control of the nuclear-cytoplasmic partitioning of annexin II by a nuclear export signal and by p11 binding. J Cell Sci 114:3155\u20133166","journal-title":"J Cell Sci"},{"key":"916_CR8","doi-asserted-by":"publisher","first-page":"6503","DOI":"10.1158\/0008-5472.Can-04-0452","volume":"64","author":"WA Freije","year":"2004","unstructured":"Freije WA, Castro-Vargas FE, Fang Z, Horvath S, Cloughesy T, Liau LM, Mischel PS, Nelson SF (2004) Gene expression profiling of gliomas strongly predicts survival. Cancer Res 64:6503\u20136510. https:\/\/doi.org\/10.1158\/0008-5472.Can-04-0452","journal-title":"Cancer Res"},{"key":"916_CR9","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1152\/physrev.00030.2001","volume":"82","author":"V Gerke","year":"2002","unstructured":"Gerke V, Moss SE (2002) Annexins: from structure to function. Physiol Rev 82:331\u2013371. https:\/\/doi.org\/10.1152\/physrev.00030.2001","journal-title":"Physiol Rev"},{"key":"916_CR10","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1056\/NEJMoa1308573","volume":"370","author":"MR Gilbert","year":"2014","unstructured":"Gilbert MR, Dignam JJ, Armstrong TS, Wefel JS, Blumenthal DT, Vogelbaum MA, Colman H, Chakravarti A, Pugh S, Won M et al (2014) A randomized trial of bevacizumab for newly diagnosed glioblastoma. N Engl J Med 370:699\u2013708. https:\/\/doi.org\/10.1056\/NEJMoa1308573","journal-title":"N Engl J Med"},{"key":"916_CR11","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1089\/104303403321618137","volume":"14","author":"JA Hampl","year":"2003","unstructured":"Hampl JA, Camp SM, Mydlarz WK, Hampl M, Ichikawa T, Chiocca EA, Louis DN, Sena-Esteves M, Breakefield XO (2003) Potentiated gene delivery to tumors using herpes simplex virus\/Epstein-Barr virus\/RV tribrid amplicon vectors. Hum Gene Ther 14:611\u2013626. https:\/\/doi.org\/10.1089\/104303403321618137","journal-title":"Hum Gene Ther"},{"key":"916_CR12","doi-asserted-by":"publisher","first-page":"387","DOI":"10.2176\/nmc.ra.2016-0077","volume":"56","author":"T Ichikawa","year":"2016","unstructured":"Ichikawa T, Otani Y, Kurozumi K, Date I (2016) Phenotypic transition as a survival strategy of Glioma. Neurol Med Chir 56:387\u2013395. https:\/\/doi.org\/10.2176\/nmc.ra.2016-0077","journal-title":"Neurol Med Chir"},{"key":"916_CR13","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/j.wneu.2011.09.005","volume":"78","author":"S Inoue","year":"2012","unstructured":"Inoue S, Ichikawa T, Kurozumi K, Maruo T, Onishi M, Yoshida K, Fujii K, Kambara H, Chiocca EA, Date I (2012) Novel animal glioma models that separately exhibit two different invasive and angiogenic phenotypes of human glioblastomas. World Neurosurg 78:670\u2013682. https:\/\/doi.org\/10.1016\/j.wneu.2011.09.005","journal-title":"World Neurosurg"},{"key":"916_CR14","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1038\/nn.4295","volume":"19","author":"A Jahani-Asl","year":"2016","unstructured":"Jahani-Asl A, Yin H, Soleimani VD, Haque T, Luchman HA, Chang NC, Sincennes MC, Puram SV, Scott AM, Lorimer IA et al (2016) Control of glioblastoma tumorigenesis by feed-forward cytokine signaling. Nat Neurosci 19:798\u2013806. https:\/\/doi.org\/10.1038\/nn.4295","journal-title":"Nat Neurosci"},{"key":"916_CR15","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.canlet.2015.01.010","volume":"359","author":"JV Joseph","year":"2015","unstructured":"Joseph JV, Conroy S, Pavlov K, Sontakke P, Tomar T, Eggens-Meijer E, Balasubramaniyan V, Wagemakers M, den Dunnen WF, Kruyt FA (2015) Hypoxia enhances migration and invasion in glioblastoma by promoting a mesenchymal shift mediated by the HIF1alpha-ZEB1 axis. Cancer Lett 359:107\u2013116. https:\/\/doi.org\/10.1016\/j.canlet.2015.01.010","journal-title":"Cancer Lett"},{"key":"916_CR16","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1227\/NEU.0b013e3181f1c0cd","volume":"67","author":"SH Kang","year":"2010","unstructured":"Kang SH, Yu MO, Park KJ, Chi SG, Park DH, Chung YG (2010) Activated STAT3 regulates hypoxia-induced angiogenesis and cell migration in human glioblastoma. Neurosurgery 67:1386\u20131395; discussion 1395. https:\/\/doi.org\/10.1227\/NEU.0b013e3181f1c0cd","journal-title":"Neurosurgery"},{"key":"916_CR17","doi-asserted-by":"publisher","unstructured":"Kling T, Ferrarese R, D Oh, Johansson P, Heiland DH, Dai F, Vasilikos I, Weyerbrock A, Jornsten R, Carro MSet al (2016) Integrative modeling reveals Annexin A2-mediated epigenetic control of Mesenchymal Glioblastoma. EBioMedicine 12: 72\u201385 Doi https:\/\/doi.org\/10.1016\/j.ebiom.2016.08.050","DOI":"10.1016\/j.ebiom.2016.08.050"},{"key":"916_CR18","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1002\/path.5010","volume":"244","author":"JA Kucia-Tran","year":"2018","unstructured":"Kucia-Tran JA, Tulkki V, Scarpini CG, Smith S, Wallberg M, Paez-Ribes M, Araujo AM, Botthoff J, Feeney M, Hughes K et al (2018) Anti-oncostatin M antibody inhibits the pro-malignant effects of oncostatin M receptor overexpression in squamous cell carcinoma. J Pathol 244:283\u2013295. https:\/\/doi.org\/10.1002\/path.5010","journal-title":"J Pathol"},{"key":"916_CR19","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1038\/bjc.2016.199","volume":"115","author":"JA Kucia-Tran","year":"2016","unstructured":"Kucia-Tran JA, Tulkki V, Smith S, Scarpini CG, Hughes K, Araujo AM, Yan KY, Botthof J, Perez-Gomez E, Quintanilla M et al (2016) Overexpression of the oncostatin-M receptor in cervical squamous cell carcinoma is associated with epithelial-mesenchymal transition and poor overall survival. Br J Cancer 115:212\u2013222. https:\/\/doi.org\/10.1038\/bjc.2016.199","journal-title":"Br J Cancer"},{"key":"916_CR20","doi-asserted-by":"publisher","unstructured":"Maruo T, Ichikawa T, Kanzaki H, Inoue S, Kurozumi K, Onishi M, Yoshida K, Kambara H, Ouchida M, Shimizu Ket al (2013) Proteomics-based analysis of invasion-related proteins in malignant gliomas. Neuropathology33: 264\u2013275 Doi https:\/\/doi.org\/10.1111\/j.1440-1789.2012.01361.x","DOI":"10.1111\/j.1440-1789.2012.01361.x"},{"key":"916_CR21","doi-asserted-by":"publisher","first-page":"32635","DOI":"10.1074\/jbc.271.51.32635","volume":"271","author":"B Mosley","year":"1996","unstructured":"Mosley B, De Imus C, Friend D, Boiani N, Thoma B, Park LS, Cosman D (1996) Dual oncostatin M (OSM) receptors. Cloning and characterization of an alternative signaling subunit conferring OSM-specific receptor activation. J Biol Chem 271:32635\u201332643. https:\/\/doi.org\/10.1074\/jbc.271.51.32635","journal-title":"J Biol Chem"},{"key":"916_CR22","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1007\/s10014-015-0216-6","volume":"32","author":"M Onishi","year":"2015","unstructured":"Onishi M, Ichikawa T, Kurozumi K, Inoue S, Maruo T, Otani Y, Fujii K, Ishida J, Shimazu Y, Yoshida K et al (2015) Annexin A2 regulates angiogenesis and invasion phenotypes of malignant glioma. Brain Tumor Pathol 32:184\u2013194. https:\/\/doi.org\/10.1007\/s10014-015-0216-6","journal-title":"Brain Tumor Pathol"},{"key":"916_CR23","doi-asserted-by":"publisher","first-page":"v1","DOI":"10.1093\/neuonc\/nox158","volume":"19","author":"QT Ostrom","year":"2017","unstructured":"Ostrom QT, Gittleman H, Liao P, Vecchione-Koval T, Wolinsky Y, Kruchko C, Barnholtz-Sloan JS (2017) CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2010-2014. Neuro-Oncology 19:v1\u2013v88. https:\/\/doi.org\/10.1093\/neuonc\/nox158","journal-title":"Neuro-Oncology"},{"key":"916_CR24","doi-asserted-by":"publisher","first-page":"285","DOI":"10.18926\/amo\/56930","volume":"73","author":"Y Otani","year":"2019","unstructured":"Otani Y, Ichikawa T, Kurozumi K, Date I (2019) Dynamic reorganization of microtubule and Glioma invasion. Acta medica Okayama 73:285\u2013297. https:\/\/doi.org\/10.18926\/amo\/56930","journal-title":"Acta medica Okayama"},{"key":"916_CR25","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1038\/onc.2017.373","volume":"37","author":"Y Otani","year":"2018","unstructured":"Otani Y, Ichikawa T, Kurozumi K, Inoue S, Ishida J, Oka T, Shimizu T, Tomita Y, Hattori Y, Uneda A et al (2018) Fibroblast growth factor 13 regulates glioma cell invasion and is important for bevacizumab-induced glioma invasion. Oncogene 37:777\u2013786. https:\/\/doi.org\/10.1038\/onc.2017.373","journal-title":"Oncogene"},{"key":"916_CR26","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1126\/science.1254257","volume":"344","author":"AP Patel","year":"2014","unstructured":"Patel AP, Tirosh I, Trombetta JJ, Shalek AK, Gillespie SM, Wakimoto H, Cahill DP, Nahed BV, Curry WT, Martuza RL et al (2014) Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma. Science 344:1396\u20131401. https:\/\/doi.org\/10.1126\/science.1254257","journal-title":"Science"},{"key":"916_CR27","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1126\/science.aaf2666","volume":"360","author":"RB Puchalski","year":"2018","unstructured":"Puchalski RB, Shah N, Miller J, Dalley R, Nomura SR, Yoon JG, Smith KA, Lankerovich M, Bertagnolli D, Bickley K et al (2018) An anatomic transcriptional atlas of human glioblastoma. Science 360:660\u2013663. https:\/\/doi.org\/10.1126\/science.aaf2666","journal-title":"Science"},{"key":"916_CR28","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1093\/jnen\/59.7.607","volume":"59","author":"NG Rainov","year":"2000","unstructured":"Rainov NG, Koch S, Sena-Esteves M, Berens ME (2000) Characterization of a canine glioma cell line as related to established experimental brain tumor models. J Neuropathol Exp Neurol 59:607\u2013613. https:\/\/doi.org\/10.1093\/jnen\/59.7.607","journal-title":"J Neuropathol Exp Neurol"},{"key":"916_CR29","doi-asserted-by":"publisher","first-page":"8117","DOI":"10.1038\/sj.onc.1206922","volume":"22","author":"P Repovic","year":"2003","unstructured":"Repovic P, Fears CY, Gladson CL, Benveniste EN (2003) Oncostatin-M induction of vascular endothelial growth factor expression in astroglioma cells. Oncogene 22:8117\u20138124. https:\/\/doi.org\/10.1038\/sj.onc.1206922","journal-title":"Oncogene"},{"key":"916_CR30","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1136\/jnnp.3.2.147","volume":"3","author":"HJ Scherer","year":"1940","unstructured":"Scherer HJ (1940) A critical review: the pathology of cerebral GLIOMAS. J Neurol Psychiatry 3:147\u2013177. https:\/\/doi.org\/10.1136\/jnnp.3.2.147","journal-title":"J Neurol Psychiatry"},{"key":"916_CR31","doi-asserted-by":"publisher","first-page":"2234","DOI":"10.1158\/1535-7163.MCT-17-0148","volume":"16","author":"K Shien","year":"2017","unstructured":"Shien K, Papadimitrakopoulou VA, Ruder D, Behrens C, Shen L, Kalhor N, Song J, Lee JJ, Wang J, Tang X et al (2017) JAK1\/STAT3 activation through a Proinflammatory cytokine pathway leads to resistance to molecularly targeted therapy in non-small cell lung Cancer. Mol Cancer Ther 16:2234\u20132245. https:\/\/doi.org\/10.1158\/1535-7163.MCT-17-0148","journal-title":"Mol Cancer Ther"},{"key":"916_CR32","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1038\/359843a0","volume":"359","author":"D Shweiki","year":"1992","unstructured":"Shweiki D, Itin A, Soffer D, Keshet E (1992) Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359:843\u2013845. https:\/\/doi.org\/10.1038\/359843a0","journal-title":"Nature"},{"key":"916_CR33","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1158\/1541-7786.MCR-16-0337","volume":"15","author":"JM Smigiel","year":"2017","unstructured":"Smigiel JM, Parameswaran N, Jackson MW (2017) Potent EMT and CSC phenotypes are induced by Oncostatin-M in pancreatic Cancer. Mol Cancer Res 15:478\u2013488. https:\/\/doi.org\/10.1158\/1541-7786.MCR-16-0337","journal-title":"Mol Cancer Res"},{"key":"916_CR34","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1186\/s12883-017-0961-8","volume":"17","author":"Q Tang","year":"2017","unstructured":"Tang Q, Lian Y, Yu J, Wang Y, Shi Z, Chen L (2017) Anatomic mapping of molecular subtypes in diffuse glioma. BMC Neurol 17:183. https:\/\/doi.org\/10.1186\/s12883-017-0961-8","journal-title":"BMC Neurol"},{"key":"916_CR35","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1158\/1535-7163.Mct-18-0799","volume":"18","author":"Y Tomita","year":"2019","unstructured":"Tomita Y, Kurozumi K, Yoo JY, Fujii K, Ichikawa T, Matsumoto Y, Uneda A, Hattori Y, Shimizu T, Otani Y et al (2019) Oncolytic herpes virus armed with Vasculostatin in combination with Bevacizumab abrogates Glioma invasion via the CCN1 and AKT signaling pathways. Mol Cancer Ther 18:1418\u20131429. https:\/\/doi.org\/10.1158\/1535-7163.Mct-18-0799","journal-title":"Mol Cancer Ther"},{"key":"916_CR36","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.ccr.2009.12.020","volume":"17","author":"RG Verhaak","year":"2010","unstructured":"Verhaak RG, Hoadley KA, Purdom E, Wang V, Qi Y, Wilkerson MD, Miller CR, Ding L, Golub T, Mesirov JP et al (2010) Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell 17:98\u2013110. https:\/\/doi.org\/10.1016\/j.ccr.2009.12.020","journal-title":"Cancer Cell"},{"key":"916_CR37","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1093\/neuonc\/nor195","volume":"14","author":"H Wakimoto","year":"2012","unstructured":"Wakimoto H, Mohapatra G, Kanai R, Curry WT Jr, Yip S, Nitta M, Patel AP, Barnard ZR, Stemmer-Rachamimov AO, Louis DN et al (2012) Maintenance of primary tumor phenotype and genotype in glioblastoma stem cells. Neuro-Oncology 14:132\u2013144. https:\/\/doi.org\/10.1093\/neuonc\/nor195","journal-title":"Neuro-Oncology"},{"key":"916_CR38","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.ccell.2017.12.012","volume":"33","author":"Q Wang","year":"2018","unstructured":"Wang Q, Hu B, Hu X, Kim H, Squatrito M, Scarpace L, deCarvalho AC, Lyu S, Li P, Li Y et al (2018) Tumor evolution of Glioma-intrinsic gene expression subtypes associates with immunological changes in the microenvironment. Cancer Cell 33:152. https:\/\/doi.org\/10.1016\/j.ccell.2017.12.012","journal-title":"Cancer Cell"},{"key":"916_CR39","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1016\/s1470-2045(17)30517-x","volume":"18","author":"M Weller","year":"2017","unstructured":"Weller M, Butowski N, Tran DD, Recht LD, Lim M, Hirte H, Ashby L, Mechtler L, Goldlust SA, Iwamoto F et al (2017) Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial. Lancet Oncol 18:1373\u20131385. https:\/\/doi.org\/10.1016\/s1470-2045(17)30517-x","journal-title":"Lancet Oncol"},{"key":"916_CR40","doi-asserted-by":"publisher","first-page":"e315","DOI":"10.1016\/s1470-2045(17)30194-8","volume":"18","author":"M Weller","year":"2017","unstructured":"Weller M, van den Bent M, Tonn JC, Stupp R, Preusser M, Cohen-Jonathan-Moyal E, Henriksson R, Le Rhun E, Balana C, Chinot O et al (2017) European Association for Neuro-Oncology (EANO) guideline on the diagnosis and treatment of adult astrocytic and oligodendroglial gliomas. The Lancet Oncology 18:e315\u2013e329. https:\/\/doi.org\/10.1016\/s1470-2045(17)30194-8","journal-title":"The Lancet Oncology"},{"key":"916_CR41","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1038\/onc.2013.105","volume":"33","author":"NR West","year":"2014","unstructured":"West NR, Murray JI, Watson PH (2014) Oncostatin-M promotes phenotypic changes associated with mesenchymal and stem cell-like differentiation in breast cancer. Oncogene 33:1485\u20131494. https:\/\/doi.org\/10.1038\/onc.2013.105","journal-title":"Oncogene"},{"key":"916_CR42","doi-asserted-by":"publisher","first-page":"E8","DOI":"10.3171\/2014.9.FOCUS14496","volume":"37","author":"M Womeldorff","year":"2014","unstructured":"Womeldorff M, Gillespie D, Jensen RL (2014) Hypoxia-inducible factor-1 and associated upstream and downstream proteins in the pathophysiology and management of glioblastoma. Neurosurg Focus 37:E8","journal-title":"Neurosurg Focus"},{"key":"916_CR43","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1111\/j.1365-2184.2012.00820.x","volume":"45","author":"B Wu","year":"2012","unstructured":"Wu B, Zhang F, Yu M, Zhao P, Ji W, Zhang H, Han J, Niu R (2012) Up-regulation of Anxa2 gene promotes proliferation and invasion of breast cancer MCF-7 cells. Cell Prolif 45:189\u2013198. https:\/\/doi.org\/10.1111\/j.1365-2184.2012.00820.x","journal-title":"Cell Prolif"},{"key":"916_CR44","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1158\/1541-7786.Mcr-08-0061","volume":"7","author":"N Young","year":"2009","unstructured":"Young N, Pearl DK, Van Brocklyn JR (2009) Sphingosine-1-phosphate regulates glioblastoma cell invasiveness through the urokinase plasminogen activator system and CCN1\/Cyr61. Mol Cancer Res 7:23\u201332. https:\/\/doi.org\/10.1158\/1541-7786.Mcr-08-0061","journal-title":"Mol Cancer Res"}],"container-title":["Acta Neuropathologica Communications"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-020-00916-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s40478-020-00916-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-020-00916-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,20]],"date-time":"2022-10-20T17:07:26Z","timestamp":1666285646000},"score":1,"resource":{"primary":{"URL":"https:\/\/actaneurocomms.biomedcentral.com\/articles\/10.1186\/s40478-020-00916-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,5]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["916"],"URL":"https:\/\/doi.org\/10.1186\/s40478-020-00916-7","relation":{},"ISSN":["2051-5960"],"issn-type":[{"value":"2051-5960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,5]]},"assertion":[{"value":"22 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 April 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the ethical committee of the Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan (approval nos. G-1960 and 1603\u2013070). Informed consent was obtained from all subjects included in the study. All animal procedures and protocols were approved by the Committee on the Ethics of Animal Experimentation at Okayama University (approval no. OKU-2018176).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"42"}}